MODELING OF ELECTRON-TUNNELING TIMES IN ASYMMETRIC DOUBLE QUANTUM-WELLS

A scattering process modeled by an imaginary potential V(I) in the wide well of an asymmetric double quantum well structure (DQWS) is used to model the electron tunneling from the narrow well. Taking V(I) approximately -5 meV, the ground resonant level lifetimes of the narrow well in the DQWS are in quantitative agreement with the experimental resonance and non-resonance tunneling times. The corresponding scattering time 66 fs is much faster than the intersubband scattering time of LO-photon emission.

COMPARISONS OF PHASE TIMES WITH TUNNELING TIMES BASED ON ABSORPTION PROBABILITIES

The times spent by an electron in a scattering event or tunnelling through a potential barrier are investigated using a method based on the absorption probabilities. The reflection and transmission times derived from this method are equal to the local Larmor times if the transmission and reflection probability amplitudes are complex analytic functions of the complex potential. The numerical results show that they coincide with the phase times except as the incident electron energy approaches zero or when the transmission probability is too small. If the imaginary potential covers the whole space the tunnelling times are again equal to the phase times. The results show that the tunnelling times based on absorption probabilities are the best of the various candidates.

瓦山安息香中苯并呋喃促雌激素合成的机理研究

雌激素是人体内重要的激素之一，具有广泛的生理功能。雌激素缺乏与许多疾病相关，如卵巢功能低下，更年期综合征以及骨质疏松等；雌激素过剩也将导致某些疾病，如乳腺癌、卵巢癌、子宫内膜癌等。目前，如何降低肿瘤组织中的雌激素水平而达到治疗肿瘤的目的，已经得到广泛的研究，但促雌激素生成或调节卵巢功能药物或其相关研究则很少。 本实验室前期的研究发现，瓦山安息香属植物果实中的乙醇提取物具有促雌激素生成作用，通过活性追踪和结构鉴定，确认促E2 生成的主要成分为苯并呋喃类化合物。苯并呋喃类化合物的作用与芳香酶有关，但其确切的作用机理有待证实和深入研究。 为了探讨安息香苯并呋喃类化合物的促雌激素合成的作用机理，拟采用如下的实验方案： 1、细胞学方面，对小鼠3T3-L1 前脂肪细胞、人乳腺癌细胞MCF-7、MDA-MB-231 以及人卵巢癌细胞OVCAR-3、OVCAR-4、OVCAR-5、OVCAR-8、IGROV1 等细胞株，采用RT-PCR 和ELISA 方法研究芳香酶Aro基因的表达和雌二醇E2 的生成，芳香酶抑制剂Formestane 作为阳性对照，研究时效曲线和量效曲线，确定安息香苯并呋喃类化合物SP25 的有效浓度和作用时间。 2、RNAi 方面，设计合成了针对人芳香酶Aro基因的3 对RNAi 序列，转染入细胞，芳香酶促进剂Forskolin 和地塞米松、芳香酶抑制剂Formestane 作为阳性对照，采用实时定量PCR 技术，研究RNA 干扰后，安息香苯并呋喃类化合物SP25 对人芳香酶Aro基因表达水平瓦山安息香苯并呋喃促雌激素合成的机理研究的影响。 3、雌激素受体方面，设计一段ERE 的雌激素调控元件，构建重组荧光素酶报告基因载体，瞬时转染人乳腺癌细胞株MDA-MB-231，建立针对雌激素受体的报告基因筛选模型，观察安息香苯并呋喃类化合物SP25 对雌激素受体的选择性和亲和力，从受体水平考察安息香苯并呋喃类化合物SP25 促进雌激素生成的药理学机理。 实验结果显示： 1、分化后的小鼠3T3-L1 前脂肪细胞、人乳腺癌细胞MCF-7 、MDA-MB-231 以及人卵巢癌细胞OVCAR-3、OVCAR-4、OVCAR-8 等细胞株具有芳香酶基因的表达。睾酮向雌二醇的转化能够被芳香酶抑制剂Formestane 所阻断，其中OVCAR-3 最适合进行下一步的RNAi研究。 2、RNAi 实验结果显示，设计的3 对RNAi 序列中R2 的干扰效果最强，相应的阴性对照C2 与R2 的表达量相差118 倍（24 小时）和19 倍（48 小时），显示R2/C2 这组序列可用于进一步的RNAi 试验。以R2 干扰OVCAR-3 细胞株，药物作用24、48 小时后，芳香酶抑制剂Formestane 与R2 相对表达量相比分别为0.83 倍和0.04 倍；芳香酶促进剂Forskolin 与R2 相对表达量相比分别为3.61 和1.84 倍；芳香酶促进剂地塞米松与R2 相对表达量相比分别为5.76 倍和3.49倍；苯并呋喃类化合物SP25 与R2 相对表达量相比分别为8.13 倍和4.59 倍。实验证实安息香苯并呋喃类化合物SP25 能够促进因RNAi 而发生基因沉默的人芳香酶Aro表达水平的上调。 3、雌激素受体实验结果显示，构建成功重组pERE-pGL3-promoter 荧光素酶报告基因载体和基于报告基因系统的雌激素受体激动剂或拮抗剂的细胞筛选模型。实验结果表明安息香苯并呋喃类化合物SP25 与雌激素受体ERα和ERβ亲和力选择性之比约为3：1 ，SP25通过与雌激素受体ERα结合作用其受体，刺激芳香酶的表达。 本课题通过RNA 干扰、ELISA、荧光实时定量PCR、报告基因筛选模型等技术手段，从细胞水平、蛋白酶水平和基因表达水平、雌激素受体水平等方面系统地研究了从瓦山安息香属植物果实中提取的苯并呋喃SP25 促进促雌激素生成的机理研究。试验结果显示苯并呋喃类化合物SP25 促雌激素生成的主要作用机制是直接促进芳香酶基因表达水平，以及与雌激素受体a 结合，刺激芳香酶活性。 Estrogen is an important hormone that has versatile physiologicalfunctions. Lack of estrogen will lead to many diseases such as lower ovarianfunction, climacteric syndrome and osteoporosis. Excessive estrogen alsoinduces breast carcinoma, oophoroma and endometrial carcinoma and otherdiseases. To depress the estrogen level in tumor tissue to cure carcinomawas widely studied, but there is only few studies reported on the induction ofestrogen and on the regulation of ovary function. We found that the extracts from seeds of Styrax perkinsiae couldpromote the synthesis of estrogen. The active compounds benzofurans wereidentified. Effect of benzofurans may be related to aromatase, but the mechanism was not clear. To reveal the mechanism of these benzofurans to promote estrogensynthesis, the following protocols were adopted: 1 Cytology: 3T3-L1 preadipocytes,human ovary carcinoma celllines OVCAR-3,OVCAR-4,OVCAR-5,OVCAR-8,IGROV1 andbreast carcinoma cell lines MCF-7 and MDA-MB-231 were usedto determine Aro gene expression and estrogen production withRT-PCR AND ELISA methods. Formestane, an aromataseinhibitor, was used as positive control. And dose-curve,time-curve and the effective concentration of SP25 were also studied. 2 Designed 3 pairs of RNAi for human aromatase gene, andtransfected into cell. Aromatase inducer Forskolin andDexamethasone, and aromatase inhibitor Formestane were usedas positive controls. We studied the change of Aro expressionlevel with SP25 by using real-time PCR after RNA interfering. 3 Estrogen Receptor: We constructed the recombined Luciferasereport vector and establish a screening system for estrogenagonist and antagon. With this system, we studied the affinity ofSP25 and estrogen receptor. Results: 1 Differentiated 3T3-L1 preadipocytes¡¢human ovary carcinomacell lines:OVCAR-3, OVCAR-4, OVCAR-8 and breast carcinomacell lines MCF-7, MDA-MB-231 had detected aromatase geneexpression.And OVCAR-3 is more suitable for further aromatasegene function research. 2 In RNAi assay, R2 has a strong interfering effcet in OVCAR-3 cellline, and ratio of C2 (the negative control) to R2 were 118 times(24 hours) and 19 times (48 hours). This means sucessful inRNA interfering. After R2 acted on OVCAR-3 cell line, the ratiosof formestane to R2 were 0.83 and 0.04 times, 5.76 and 3.49times (Dex), 3.61 and 1.84 times (forskolin) and 8.13 and 4.59times (sp25) after drug treated 24 or 48 hours respectively.These results indicated that SP25 can directly induce aromatasegene up-regulation. 3 We had constructed pERE-pGL3-promoter recombined vectorand the Luciferase report gene screening system. Luciferasereport gene assay showed that sp25 had a higher affinity with strogen receptor alpha than estrogen receptor beta, this indicated that SP25 can act on estrogen receptor and induce aromatase. Our results revealed that the mechanisms of benzofuran to promoteestrogen were the upregulation aromatase gene expression and promotion ofaromatase activity and have partially elective affinity with estrogen receptoralpha.

制革废水生物强化处理及中水回用试验研究

制革行业是轻工行业中仅次于造纸业的高耗水、重污染行业，作为劳动密集型行业，在解决大量人口就业问题的同时，也对所在地区环境造成了严重污染。目前我国制革行业每年排放废水8,000~12,000万吨，废水中含铬约3,500 t，SS为1.2×105 t，COD为1.8×105 t，BOD为7×104 t，对水体污染严重。 本研究在对厌氧酸化工艺进行研究、一级好氧处理段进行工艺比选研究的基础上，获得了匀质调节—SBBR—BAF的生物处理工艺，并依托该工艺进行了生物强化处理的研究，考察了菌剂的强化运行效果及其处理水回用的可行性。 研究表明，在进水COD＞3,000 mg/L，厌氧酸化具有很好的抗冲击作用，保证了好氧工艺出水COD＜200 mg/L；在进水COD＜3,000 mg/L，可只通过好氧处理实现出水COD＜200 mg/L。厌氧酸化停留时间选择不当，会导致厌氧出水硫化物浓度升高，严重影响好氧系统，会使好氧活性污泥因中毒而解絮。 研究表明，当进水COD为2,000~2,500 mg/L，NH4+-N为130~146 mg/L时，COD、NH4+-N去除率SBBR分别为93.8%~96.6%和14.5%~55.9%，SBR分别为88.8%~94.9%和13%~50.7%，表明SBBR优于SBR。同时，研究发现SBBR污泥增长率为0.05 kgVSS/kgCOD，仅为SBR0.57 kgVSS/kgCOD的8.8%。此外，研究发现SBBR在停止运行后经3个运行周期可回复原油能力，而SBR池经9个周期培养也不能恢复，说明SBBR恢复能力明显优于SBR。 研究表明，以匀质调节—SBBR—BAF为主的制革废水处理工艺，出水水质稳定，进水COD 801~2,834 mg/L、NH4+-N 87~203 mg/L，出水COD＜80 mg/L、NH4+-N＜10 mg/L，基本达到中水回用标准；操作简单灵活，没有污泥回流系统，污泥产率低，污泥处理费用低；工艺基本不需要添加化学药剂，既节约成本、又避免了二次污染；两级生物膜使得该工艺具有很强的耐冲击负荷能力，特别适合制革废水水质水量波动大的特点。 研究表明，高效菌对系统的启动具有一定的促进作用，强化系统生物膜6天可以成熟，对照系统生物膜9天可以成熟。同时高效菌能加速COD降解，缩短停留时间，强化系统6~8 h可使COD＜200 mg/L，对照系统8~10 h可使COD＜200 mg/L。长期运行表明，强化系统的SBBR在COD和NH4+-N的去除率都优于对照系统的SBBR。最终出水COD强化系统平均为53 mg/L、对照系统为74 mg/L。在模拟循环过程中，强化系统均有更高的稳定性。可实现8次理论循环，而对照系统只能实现4次理论循环。 研究表明，通过合理的工艺设计，可以实现猪皮制革废水达到《污水综合排放标准GB8976-1996》一级标准，同时满足工厂部分用水要求。通过添加高效微生物，可提高生物处理系统处理能力，使处理水能够满足工厂的多次回用。 As a labour-intensive industry, tanning has created large amount of working opportunities as well as caused severe contamination to environment. And it is one of the highest water-consuming and polluting industry, only second to manufacturing. At present time, Chinese leather industry emits wastewater about 80,000,000~120,000,000 t annually, which contains chromium about 3,500 t, SS 1.2×105 t, COD 1.8×105 t, BOD 7×104 t and ambient riverhead has been polluted greatly. Based on the research of anaerobic acidification and comparison of SBBR and SBR, biotreatment process (Homogenization—SBBR—BAF) had been established to amend the disadvantages of traditional sewage treatment such as too much sludge, high cost of advanced treatment and NH4+-N can not reach the emission standard. Research on the bioaugmentation was also been carried out. Researches showed, when COD of influent was beyond 3,000 mg/L, anaerobic acidification could resist strong impact, thus COD of effluent was less than 200 mg/L; when COD of influent was less than 3,000 mg/L, only throughout aerobic sewage treatment could COD of effluent beless than 200 mg/L. False residence tiome of anaerobic acidification would lead to the higher effluent concentration of sulfide and disintegration of aerobic activated sludge. Researches showed SBBR worked a better than SBR: when influent between 2,000 and 2,500 mg/L, NH4+-N between 130 mg/L and 146 mg/L, COD, NH4+-N removal rate of SBBR was 93.3%~96.6%, 14.5%~55.9% respectively while COD, NH4+-N removal rate of SBR was 88.8%~94.9%, 13%~50.7% respectively. Sludge growth rate of SBBR was 8.8% of that of 0.05 kgVSS/kgCOD. Besides, SBBR could recovered after 3 operating periods while SBR worked no better after 9 operating periods.Therefore, SBBR excelled SBR. Researches showed, effluent quantity of tannery wastewater treatment process (Homogenization—SBBR—BAF) was stable. When COD of influent was between 801 and 2,834 mg/L, NH4+-N was between 87 mg/L and 203 mg/L, COD of effluent was less than 80 mg/L, NH4+-N was less than 10 mg/L, which achieved the standard of reuse. This biotreatment was featured in low cost, easy and flexible management, less sludge, no inverse sludge system. Besides, this technique required no chemical, which could lower the cost and avoid secondary pollution. Great resistant of impact due to two membranes and was suitable for tannery wastewater which was featured by fluctuation of influent quality and quantity. Researches showed effective microorganisms promotes the startup of the process.Biofilm in the bioaugmentation process matured with 6 days while biofilm in normal process matured with 9 days. Effective microorganisms could accelerate the degradation of COD and shorten the residence time. Aggrandizement system could make COD<200 mg/L with 6 to8 hours while cntrolling system could make COD<200 mg/L with 8 to 10 hours. Long-term operating shows that SBBR in the bioaugmentation system worked better than the normal system in the treatment of COD and NH4+-N. The average COC of effluent in bioaugmentation system was 53 mg/L, normal system was 74 mg/L. In the simulative circulation process,aggrandizement process, which could fulfill 8 times theoretical circulation, works more stably than controlling process which could only fulfill 4 times theoretical circulation. Researches showed that reasonable design could make the wastewater meet the first grade of discharging standard of National Integrated Wastewater Discharge Standard (GB8976-1996), and partially meet the demand of water using of the factory. Adding effective microorganisms could enhance the biotreatment and make the effluents reuse many times.